Indraprastha Medical Past Earnings Performance
Past criteria checks 6/6
Indraprastha Medical has been growing earnings at an average annual rate of 38.7%, while the Healthcare industry saw earnings growing at 22.7% annually. Revenues have been growing at an average rate of 13.7% per year. Indraprastha Medical's return on equity is 28.2%, and it has net margins of 11.2%.
Key information
38.7%
Earnings growth rate
38.7%
EPS growth rate
| Healthcare Industry Growth | 29.4% |
| Revenue growth rate | 13.7% |
| Return on equity | 28.2% |
| Net Margin | 11.2% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
The Trend Of High Returns At Indraprastha Medical (NSE:INDRAMEDCO) Has Us Very Interested
Dec 03
Calculating The Fair Value Of Indraprastha Medical Corporation Limited (NSE:INDRAMEDCO)
Oct 14We Take A Look At Why Indraprastha Medical Corporation Limited's (NSE:INDRAMEDCO) CEO Compensation Is Well Earned
Sep 18Indraprastha Medical's (NSE:INDRAMEDCO) Shareholders Will Receive A Bigger Dividend Than Last Year
Aug 30Indraprastha Medical's (NSE:INDRAMEDCO) Shareholders Will Receive A Bigger Dividend Than Last Year
Aug 11Indraprastha Medical Corporation Limited (NSE:INDRAMEDCO) Soars 34% But It's A Story Of Risk Vs Reward
Aug 08Investors Should Be Encouraged By Indraprastha Medical's (NSE:INDRAMEDCO) Returns On Capital
Jun 12Indraprastha Medical Corporation Limited (NSE:INDRAMEDCO) Shares Fly 42% But Investors Aren't Buying For Growth
Apr 06Why Investors Shouldn't Be Surprised By Indraprastha Medical Corporation Limited's (NSE:INDRAMEDCO) Low P/E
Feb 01Why The 29% Return On Capital At Indraprastha Medical (NSE:INDRAMEDCO) Should Have Your Attention
Nov 03We Think Indraprastha Medical Corporation Limited's (NSE:INDRAMEDCO) CEO Compensation Looks Fair
Sep 15Indraprastha Medical's (NSE:INDRAMEDCO) Dividend Will Be Increased To ₹3.00
Sep 10Indraprastha Medical's (NSE:INDRAMEDCO) Upcoming Dividend Will Be Larger Than Last Year's
Aug 27Indraprastha Medical (NSE:INDRAMEDCO) Is Paying Out A Larger Dividend Than Last Year
Aug 08Why We Like The Returns At Indraprastha Medical (NSE:INDRAMEDCO)
Jul 31Indraprastha Medical (NSE:INDRAMEDCO) Is Very Good At Capital Allocation
Jan 21We Think Indraprastha Medical's (NSE:INDRAMEDCO) Profit Is Only A Baseline For What They Can Achieve
Nov 12Estimating The Intrinsic Value Of Indraprastha Medical Corporation Limited (NSE:INDRAMEDCO)
Nov 02Why We Like The Returns At Indraprastha Medical (NSE:INDRAMEDCO)
May 12Estimating The Intrinsic Value Of Indraprastha Medical Corporation Limited (NSE:INDRAMEDCO)
Jun 10Introducing Indraprastha Medical (NSE:INDRAMEDCO), A Stock That Climbed 24% In The Last Year
Feb 21Revenue & Expenses Breakdown
How Indraprastha Medical makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 13,189 | 1,478 | 1,066 | 0 |
| 30 Jun 24 | 12,861 | 1,382 | 0 | 0 |
| 31 Mar 24 | 12,447 | 1,240 | 1,066 | 0 |
| 31 Dec 23 | 12,040 | 1,126 | 912 | 0 |
| 30 Sep 23 | 11,745 | 1,041 | 912 | 0 |
| 30 Jun 23 | 11,419 | 964 | 0 | 0 |
| 31 Mar 23 | 10,987 | 862 | 895 | 0 |
| 31 Dec 22 | 10,411 | 815 | 552 | 0 |
| 30 Sep 22 | 10,000 | 765 | 552 | 0 |
| 30 Jun 22 | 9,486 | 635 | 0 | 0 |
| 31 Mar 22 | 8,882 | 586 | 552 | 0 |
| 31 Dec 21 | 8,705 | 585 | 284 | 0 |
| 30 Sep 21 | 8,139 | 546 | 284 | 0 |
| 30 Jun 21 | 7,221 | 430 | 0 | 0 |
| 31 Mar 21 | 6,134 | 23 | 285 | 0 |
| 31 Dec 20 | 6,158 | -63 | 510 | 0 |
| 30 Sep 20 | 6,462 | -76 | 510 | 0 |
| 30 Jun 20 | 7,213 | 99 | 510 | 0 |
| 31 Mar 20 | 8,308 | 436 | 510 | 0 |
| 31 Dec 19 | 8,307 | 443 | 483 | 0 |
| 30 Sep 19 | 8,185 | 407 | 483 | 0 |
| 30 Jun 19 | 8,025 | 305 | 0 | 0 |
| 31 Mar 19 | 7,882 | 284 | 483 | 0 |
| 31 Dec 18 | 7,734 | 269 | 437 | 0 |
| 30 Sep 18 | 7,610 | 253 | 437 | 0 |
| 30 Jun 18 | 7,527 | 228 | 0 | 0 |
| 31 Mar 18 | 7,527 | 211 | 437 | 0 |
| 31 Dec 17 | 7,471 | 202 | 448 | 0 |
| 30 Sep 17 | 7,537 | 207 | 448 | 0 |
| 30 Jun 17 | 7,564 | 228 | 0 | 0 |
| 31 Mar 17 | 7,657 | 262 | 437 | 0 |
| 31 Dec 16 | 7,660 | 304 | 437 | 0 |
| 30 Sep 16 | 7,635 | 283 | 437 | 0 |
| 30 Jun 16 | 7,640 | 296 | 437 | 0 |
| 31 Mar 16 | 7,554 | 244 | 428 | 0 |
| 31 Dec 15 | 7,472 | 303 | 937 | 0 |
| 30 Sep 15 | 7,340 | 323 | 937 | 0 |
| 30 Jun 15 | 7,226 | 321 | 0 | 0 |
| 31 Mar 15 | 7,145 | 325 | 412 | 0 |
| 31 Dec 14 | 7,016 | 321 | 784 | 0 |
| 30 Sep 14 | 6,949 | 331 | 784 | 0 |
| 30 Jun 14 | 6,897 | 342 | 0 | 0 |
| 31 Mar 14 | 6,776 | 354 | 805 | 0 |
| 31 Dec 13 | 6,663 | 347 | 660 | 0 |
Quality Earnings: INDRAMEDCO has high quality earnings.
Growing Profit Margin: INDRAMEDCO's current net profit margins (11.2%) are higher than last year (8.9%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: INDRAMEDCO's earnings have grown significantly by 38.7% per year over the past 5 years.
Accelerating Growth: INDRAMEDCO's earnings growth over the past year (42%) exceeds its 5-year average (38.7% per year).
Earnings vs Industry: INDRAMEDCO earnings growth over the past year (42%) exceeded the Healthcare industry 29.6%.
Return on Equity
High ROE: INDRAMEDCO's Return on Equity (28.2%) is considered high.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/22 05:57 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Indraprastha Medical Corporation Limited is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Ranjit Kapadia | Centrum Broking Limited |
| Kameswari V. S. Chavali | FirstCall Research |